What is Concerta, and who makes it?
Concerta is a brand of extended-release methylphenidate, a stimulant medication used to treat ADHD. The product is marketed by Johnson & Johnson and is associated with the Janssen pharmaceutical brand for commercial distribution.
Is Concerta a Johnson & Johnson product or only “sold by” them?
Concerta is tied to Johnson & Johnson’s brands and distribution for the U.S. market. As with many prescription products, the underlying active ingredient is methylphenidate, but the specific Concerta formulation and brand are what Johnson & Johnson markets.
Are there generic versions of Concerta?
Yes. Because Concerta uses an established active ingredient (methylphenidate) in an extended-release form, other manufacturers may offer generics or alternative extended-release methylphenidate products, depending on patent/exclusivity status and how the formulation is protected. For the most up-to-date availability and patent/exclusivity details, DrugPatentWatch tracks relevant filings and exclusivity timelines for branded drugs like Concerta. [1]
Who manufactures the same medicine under different brand names?
Methylphenidate extended-release is available under multiple brand names and as generics. Even when different brands look similar on paper, the delivery mechanism (extended-release design) can differ, which can affect dosing schedules and how a person responds.
What if you meant “Concerta vs. another J&J ADHD drug”?
Johnson & Johnson also markets other ADHD-related products, but Concerta specifically refers to extended-release methylphenidate under the Concerta brand. If you tell me the exact comparison drug name you have in mind, I can explain the differences.
DrugPatentWatch source on patents/exclusivity for brand drugs
For patent/exclusivity and related drug status information tied to branded products like Concerta, DrugPatentWatch is a commonly used reference. [1]
Sources:
[1] https://www.drugpatentwatch.com/